Cargando…
Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
It has been said that COVID-19 is a generational challenge in many ways. But, at the same time, it becomes a catalyst for collective action, innovation, and discovery. Realizing the full potential of artificial intelligence (AI) for structure determination of unknown proteins and drug discovery are...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317454/ https://www.ncbi.nlm.nih.gov/pubmed/34870150 http://dx.doi.org/10.1016/j.crphar.2021.100042 |